PN,41201
SC,0001
CT,2,C
PS,c008
OL,0,        ECIMSBWebfax     F412A1737596027
OL,3,CScientists to give volunteers malaria
OL,4,Cto study long-term effects
OL,6,FVolunteers are to be sent from Oxford
OL,7,Fto the Netherlands to be deliberately
OL,8,Finfected with a form of malaria, so
OL,9,Fscientists can study its effects.
OL,11,FPlasmodium vivax is a type of malaria
OL,12,Fthat can remain dormant in the liver.
OL,14,FIt can reactivate months or even years
OL,15,Fafter a person was first infected,
OL,16,Fcausing relapsing infections.
OL,1,W~s1x0~s1~s hw1~k4~c1 hw}h7}j7}   G1/8
OL,2,W,.!" ,.!+, "-$/*%+.!+,*%/*%/*-'T(,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext PageBS-SE Eng NewsCThis DayFReg TV
FL,413,410,120,260,000,100
PN,41202
SC,0002
CT,2,C
PS,c008
OL,0,        ECIMSBWebfax     F412A1737596027
OL,3,CScientists to give volunteers malaria
OL,4,Cto study long-term effects
OL,6,FScientists from the Oxford Vaccine
OL,7,FGroup want to understand more about
OL,8,Fthis relapsing infection in the months
OL,9,Fafter a person is initially infected
OL,10,Fthrough the bite of a mosquito.
OL,12,FIn order to do so, they are sending
OL,13,Ffive healthy people to be bitten by
OL,14,Finfected mosquitoes at a lab in the
OL,15,FNetherlands.
OL,17,FThey will then return to Oxford, where
OL,18,Fthey can be monitored, before being
OL,19,Ftreated to stop the potential relapses.
OL,1,W~s1x0~s1~s hw1~k4~c1 hw}h7}j7}   G2/8
OL,2,W,.!" ,.!+, "-$/*%+.!+,*%/*%/*-'T(,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext PageBS-SE Eng NewsCThis DayFReg TV
FL,413,410,120,260,000,100
PN,41203
SC,0003
CT,2,C
PS,c008
OL,0,        ECIMSBWebfax     F412A1737596027
OL,3,CScientists to give volunteers malaria
OL,4,Cto study long-term effects
OL,6,FHuman challenge studies involve
OL,7,Fresearchers deliberately exposing
OL,8,Fhealthy volunteers to infectious
OL,9,Fdiseases.
OL,11,FThis allows them to monitor how the
OL,12,Fbody responds to the disease.
OL,14,FProfessor Angela Minassian, chief
OL,15,Finvestigator for the trial from the
OL,16,FUniversity of Oxford, said: "This
OL,17,Fproof-of-concept study is the first of
OL,18,Fits kind to safely introduce relapsing
OL,19,Fvivax malaria infections in healthy
OL,20,Fvolunteers under controlled research
OL,21,Fconditions.
OL,26,@xD@]OU
OL,1,W~s1x0~s1~s hw1~k4~c1 hw}h7}j7}   G3/8
OL,2,W,.!" ,.!+, "-$/*%+.!+,*%/*%/*-'T(,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext PageBS-SE Eng NewsCThis DayFReg TV
FL,413,410,120,260,000,100
PN,41204
SC,0004
CT,2,C
PS,c008
OL,0,        ECIMSBWebfax     F412A1737596027
OL,3,CScientists to give volunteers malaria
OL,4,Cto study long-term effects
OL,6,F"By doing so, we aim to answer key
OL,7,Fquestions about relapses and how the
OL,8,Fimmune system responds to them.
OL,10,F"We know that more than 80% of vivax
OL,11,Fmalaria globally is due to relapsing
OL,12,Finfections and they cause significant
OL,13,Fillness in both adults and children in
OL,14,Fmany parts of the world.
OL,16,F"Our work, if successful, aims to
OL,17,Fprovide a model for testing novel
OL,18,Fvaccines or drugs which can eliminate
OL,19,Fit from the liver and stop relapses
OL,20,Faltogether.
OL,26,@nD@AOUrD@AOUxD@AOU
OL,1,W~s1x0~s1~s hw1~k4~c1 hw}h7}j7}   G4/8
OL,2,W,.!" ,.!+, "-$/*%+.!+,*%/*%/*-'T(,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext PageBS-SE Eng NewsCThis DayFReg TV
FL,413,410,120,260,000,100
PN,41205
SC,0005
CT,2,C
PS,c008
OL,0,        ECIMSBWebfax     F412A1737596027
OL,3,CScientists to give volunteers malaria
OL,4,Cto study long-term effects
OL,6,F"This could transform how we combat
OL,7,Fthis challenging disease."
OL,9,FThe new study, a "malaria challenge
OL,10,Fstudy", has been launched by the
OL,11,FUniversity of Oxford in partnership
OL,12,Fwith the Draper Lab with a view to
OL,13,Ftransform understanding about this
OL,14,Fform of malaria.
OL,16,FThe study, known as BIO-006, will see
OL,17,Ffive healthy people aged 18 to 45
OL,18,Ftravel to the Radboud University
OL,19,FMedical Centre in Nijmegen, to be
OL,20,Fbitten by mosquitoes carrying the
OL,21,FPlasmodium vivax parasite.
OL,26,@nD@AOUoD@ZO]qD@ROUrD@FO]
OL,1,W~s1x0~s1~s hw1~k4~c1 hw}h7}j7}   G5/8
OL,2,W,.!" ,.!+, "-$/*%+.!+,*%/*%/*-'T(,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext PageBS-SE Eng NewsCThis DayFReg TV
FL,413,410,120,260,000,100
PN,41206
SC,0006
CT,2,C
PS,c008
OL,0,        ECIMSBWebfax     F412A1737596027
OL,3,CScientists to give volunteers malaria
OL,4,Cto study long-term effects
OL,6,FFollowing the mosquito bite,
OL,7,Fparticipants will return to the Centre
OL,8,Ffor Clinical Vaccinology and Tropical
OL,9,FMedicine in Oxford.
OL,11,FThose involved with the study will be
OL,12,Fmonitored daily for the first six days
OL,13,Fover the phone and in person from day
OL,14,Fseven onwards.
OL,16,FWhen malaria is detected in the blood,
OL,17,Fpeople will be "promptly" given anti-
OL,18,Fmalarial medication.
OL,20,FBut this treatment will not eliminate
OL,21,Fdormant parasites in the liver.
OL,26,@yD@POUyD@YO]
OL,1,W~s1x0~s1~s hw1~k4~c1 hw}h7}j7}   G6/8
OL,2,W,.!" ,.!+, "-$/*%+.!+,*%/*%/*-'T(,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext PageBS-SE Eng NewsCThis DayFReg TV
FL,413,410,120,260,000,100
PN,41207
SC,0007
CT,2,C
PS,c008
OL,0,        ECIMSBWebfax     F412A1737596027
OL,3,CScientists to give volunteers malaria
OL,4,Cto study long-term effects
OL,6,FThis means that scientists can study
OL,7,Frelapsing malaria infections over the
OL,8,Fnext six months.
OL,10,FDuring this period, people involved
OL,11,Fwith the study will have fortnightly
OL,12,Fcheck-ups and will have 24/7 medical
OL,13,Fsupport to address any symptoms which
OL,14,Fsuggest a relapse.
OL,16,FAny relapse infections will be treated
OL,17,Fwith anti-malarial medication.
OL,1,W~s1x0~s1~s hw1~k4~c1 hw}h7}j7}   G7/8
OL,2,W,.!" ,.!+, "-$/*%+.!+,*%/*%/*-'T(,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext PageBS-SE Eng NewsCThis DayFReg TV
FL,413,410,120,260,000,100
PN,41208
SC,0008
CT,2,C
PS,c008
OL,0,        ECIMSBWebfax     F412A1737596027
OL,3,CScientists to give volunteers malaria
OL,4,Cto study long-term effects
OL,6,FAt the end of the six-month period,
OL,7,Fall those involved in the study will
OL,8,Fbe given anti-malarial tablets with an
OL,9,Fadditional medication called
OL,10,FPrimaquine that clears dormant
OL,11,Fparasites from the liver.
OL,13,FThey will then be followed up for five
OL,14,Fmore years to monitor for any
OL,15,Funexpected relapses.
OL,1,W~s1x0~s1~s hw1~k4~c1 hw}h7}j7}   G8/8
OL,2,W,.!" ,.!+, "-$/*%+.!+,*%/*%/*-'T(,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext PageBS-SE Eng NewsCThis DayFReg TV
FL,413,410,120,260,000,100
